Ritonavir Completed Phase 4 Trials for Drug Drug Interaction (DDI) Basic Science
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Basic Science | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT04531072 | Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine |